Company Overview and News

 
NCLAT asks Eveready to pay over Rs17 crore in connection with CCI penalty

2018-05-09 livemint
New Delhi: The National Company Law Appellate Tribunal (NCLAT) on Wednesday asked Eveready Industries to pay more than Rs17.1 crore in connection with an appeal moved by the company against a Rs171.55 crore penalty imposed on it by the Competition Commission of India (CCI) for cartelisation in pricing of zinc-carbon dry cell batteries.

 
Eveready shares dive nearly 11% after CCI fine

2018-04-20 thehindubusinessline
Shares of Eveready plunged nearly 11 per cent a day after fair trade regulator CCI imposed a fine of Rs 171.55 crore on the company for cartelisation in pricing of zinc-carbon dry cell batteries.

 
Market Live: Sensex weak as banks, global cues weigh; tech stocks extend rally

2018-04-20 moneycontrol
2:35 pm TCS eyes USD 100 billion in market cap: TCS is the most valued company at Dalal Street, with a market capitalisation of Rs 6.5 lakh crore and inching towards to become the first USD 100 billion company after its healthy earnings performance and strong commentary.

 
Market Live: Nifty Bank falls 200 pts, IT index up 4%; TCS jumps 6%, RIL HDFC drag

2018-04-20 moneycontrol
12:45 pm Market Update: The market remained under selling pressure following negative lead from global stocks. But the sharp rally in technology stocks post TCS' Q4 FY18 result and a weak rupee continued to support benchmark indices.

 
Market Live: IT only gainer among sectoral indices, TCS adds Rs 40,000 cr to market cap

2018-04-20 moneycontrol
11:50 am Market Update: The market remained under selling pressure due to global weakness, but the sharp rally in technology stocks post TCS Q4 results and weak rupee capped the losses of benchmark indices.

 
Market Live: 13-month low rupee lifts Nifty IT over 3%, but other sectoral indices down

2018-04-20 moneycontrol
10:55 am Buzzing: Eveready Industries plunged 10 percent after fair trade regulator CCI imposed a total fine of Rs 215 crore on Eveready as well as Indo National, industry grouping AIDCM and their officials for cartelisation in pricing of zinc carbon dry cell batteries.

 
Battery makers take Rs 215-cr CCI shock for cartelization

2018-04-20 freepressjournal.in
New Delhi : Fair trade regulator CCI on Thursday imposed a total fine of Rs 215 crore on Eveready, Indo National, industry grouping AIDCM and their officials for cartelisation in pricing of zinc carbon dry cell batteries.

 
CCI slaps Rs 215 cr fine on Eveready, Indo National, others, for unfair biz ways

2018-04-19 moneycontrol
Fair trade regulator CCI today imposed a total fine of Rs 215 crore on Eveready, Indo National, industry grouping AIDCM and their officials for cartelisation in pricing of zinc carbon dry cell batteries.

 
Panasonic Energy India Company to hold board meeting

2016-07-06 indiainfoline
The company’s standalone revenue stood at Rs. 544.72 crore, up 10.87% yoy but down 11.8% ...

 
Manish Sharma elevated as Executive Officer, Panasonic Corp

2016-04-06 moneycontrol
Manish Sharma has become the first Indian to be appointed as Executive Officer, Panasonic Corporation, the company said in a statement.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

14h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

14h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...